Zulrahman Erlangga

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 1

Top Topics

Tissue Engineering

Kidney Transplantation

Acute Ischemic Stroke

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Uwe Hoff, Denise Markmann, Daniela Thurn-Valassina, Melina Nieminen-Kelhä, Zulrahman Erlangga, Jessica Schmitz, Jan Hinrich Bräsen, Klemens Budde, Anette Melk, Theres Schaub
The mTOR inhibitor Rapamycin protects from premature cellular senescence early after experimental kidney transplantation. PloS one 17 (4) (2022)